Specifically, CD8+ T cells require metabolic reprogramming to differentiate into effector cells capable of killing tumor cells.[35, 36] Inhibiting key metabolic pathways in tumor cells may also simultaneously limit the metabolic resources available to immune cells, thereby reducing their efficacy. Here, CD8A is linked to neoplasm.